Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2010 | 12-2009 | 09-2009 | 06-2009 | 03-2009 | |
| Sales | 1,523 | 17,155 | 5,419 | 5,469 | 20,904 |
| Gross Profit | 1,523 | 17,155 | 5,419 | 5,469 | 20,904 |
| Operating Expenses | 20,121 | 17,818 | 18,556 | 21,421 | 23,482 |
| Operating Income | -18,598 | -663 | -13,137 | -15,952 | -2,578 |
| Other Income | 15 | 24 | 123 | 781 | 790 |
| Pre-tax Income | -18,583 | -639 | -13,014 | -15,171 | -1,788 |
| Net Income Continuous | -18,583 | -639 | -13,014 | -15,171 | -1,788 |
| Net Income | $-18,583 | $-639 | $-13,014 | $-15,171 | $-1,788 |
| EPS Basic Total Ops | -0.58 | -0.02 | -0.41 | -0.49 | -0.06 |
| EPS Basic Continuous Ops | -0.58 | -0.02 | -0.41 | -0.49 | -0.06 |
| EPS Diluted Total Ops | -0.58 | -0.02 | -0.41 | -0.49 | -0.06 |
| EPS Diluted Continuous Ops | -0.58 | -0.02 | -0.41 | -0.49 | -0.06 |
| EBITDA(a) | $-17,721 | $788 | $-11,873 | $-14,202 | $-1,076 |